Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-08
DOI
10.3389/fendo.2020.00293
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FGF23, hypophosphatemia and genetic disorders
- (2019) Justine Bacchetta et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pharmacological Npt2a Inhibition Causes Phosphaturia and Reduces Plasma Phosphate in Mice with Normal and Reduced Kidney Function
- (2019) Linto Thomas et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update
- (2018) Markus Ketteler et al. ANNALS OF INTERNAL MEDICINE
- Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury
- (2018) Luis Toro et al. KIDNEY INTERNATIONAL
- Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?
- (2018) Debora Claramunt-Taberner et al. PEDIATRIC NEPHROLOGY
- FGF23 Actions on Target Tissues—With and Without Klotho
- (2018) Beatrice Richter et al. Frontiers in Endocrinology
- Topical sodium thiosulfate for calcinosis cutis associated with autoimmune connective tissue diseases: the Mayo Clinic experience, 2012-2017
- (2018) J. E. Ma et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- ANGIOID STREAKS
- (2018) Irini Chatziralli et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Autoimmune hyperphosphatemic tumoral calcinosis in a patient with FGF23 autoantibodies
- (2018) Mary Scott Roberts et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy of intralesional sodium thiosulfate injections for disabling tumoral calcinosis: Two cases
- (2017) J. Goossens et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Hartsfield syndrome associated with a novel heterozygous missense mutation inFGFR1and incorporating tumoral calcinosis
- (2016) Rathi Prasad et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Posttranslational processing of FGF23 in osteocytes during the osteoblast to osteocyte transition
- (2016) Hiroyuki Yamamoto et al. BONE
- Phenotypic and Genotypic Characterization and Treatment of a Cohort With Familial Tumoral Calcinosis/Hyperostosis-Hyperphosphatemia Syndrome
- (2016) Mary Scott Ramnitz et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Topical Sodium Thiosulfate: A Treatment for Calcifications in Hyperphosphatemic Familial Tumoral Calcinosis?
- (2016) Jérémy Jost et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dental findings of hyperphosphatemic familial tumoral calcinosis
- (2016) Hümeyra Özge Yılancı et al. Oral Radiology
- Human Preosteoblastic Cell Culture from a Patient with Severe Tumoral Calcinosis-Hyperphosphatemia Due to a New GALNT3 Gene Mutation: Study of In Vitro Mineralization
- (2015) L. Masi et al. CALCIFIED TISSUE INTERNATIONAL
- Phosphorus
- (2015) Mona S Calvo et al. Advances in Nutrition
- Root anomalies and dentin dysplasia in autosomal recessive hyperphosphatemic familial tumoral calcinosis (HFTC)
- (2015) Alexandre R. Vieira et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Hyperphosphatemic familial tumoral calcinosis: Response to acetazolamide and postulated mechanisms
- (2014) Gal Finer et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Long-term clinical outcome and phenotypic variability in hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3mutation; case report and review of the literature
- (2014) Silje Rafaelsen et al. BMC GENETICS
- Nicotinamide treatment in a murine model of familial tumoral calcinosis reduces serum Fgf23 and raises heart calcium
- (2014) Austin M. Reilly et al. BONE
- High Dietary Phosphate Intake Induces Development of Ectopic Calcifications in a Murine Model of Familial Tumoral Calcinosis
- (2014) Shoji Ichikawa et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing
- (2014) Anuja Shah et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis
- (2014) V. S. Tagliabracci et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sodium Thiosulfate Therapy for Calcific Uremic Arteriolopathy
- (2013) S. U. Nigwekar et al. Clinical Journal of the American Society of Nephrology
- Sodium Thiosulfate: Mythical Treatment for a Mysterious Disease?
- (2013) W. C. O'Neill Clinical Journal of the American Society of Nephrology
- A Mouse with an N-Ethyl-N-Nitrosourea (ENU) Induced Trp589Arg Galnt3 Mutation Represents a Model for Hyperphosphataemic Familial Tumoural Calcinosis
- (2012) Christopher T. Esapa et al. PLoS One
- Dietary Phosphate Restriction Normalizes Biochemical and Skeletal Abnormalities in a Murine Model of Tumoral Calcinosis
- (2011) Shoji Ichikawa et al. ENDOCRINOLOGY
- Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis
- (2011) Alan Yancovitch et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Clinical variability of familial tumoral calcinosis caused by novelGALNT3mutations
- (2010) Shoji Ichikawa et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Ablation of theGalnt3Gene Leads to Low-Circulating Intact Fibroblast Growth Factor 23 (Fgf23) Concentrations and Hyperphosphatemia Despite IncreasedFgf23Expression
- (2009) Shoji Ichikawa et al. ENDOCRINOLOGY
- Familial Tumoral Calcinosis Caused by a Novel FGF23 Mutation: Response to Induction of Tubular Renal Acidosis with Acetazolamide and the Non-Calcium Phosphate Binder Sevelamer
- (2009) Juan Javier Lammoglia et al. HORMONE RESEARCH
- A Novel Recessive Mutation of Fibroblast Growth Factor-23 in Tumoral Calcinosis
- (2009) L Masi et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Familial Tumoral Calcinosis: A Forty-Year Follow-up on One Family
- (2009) Kelly D Carmichael et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Defective O-Glycosylation due to a Novel Homozygous S129P Mutation Is Associated with Lack of Fibroblast Growth Factor 23 Secretion and Tumoral Calcinosis
- (2009) Clemens Bergwitz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A novel missense mutation in GALNT3 causing hyperostosis–hyperphosphataemia syndrome.
- (2008) Hannes Olauson et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A case of familial tumoral calcinosis/hyperostosis–hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features
- (2008) C. E. Dumitrescu et al. OSTEOPOROSIS INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now